Latest Breaking News On - Cyclacel pharmaceuticals trading down - Page 1 : vimarsana.com

Cyclacel Pharmaceuticals, Inc (NASDAQ:CYCC) Sees Large Increase in Short Interest

Cyclacel Pharmaceuticals, Inc (NASDAQ:CYCC) Sees Large Increase in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cyclacel pharmaceuticals trading downCyclacel pharmaceuticals company profileNews ratings for cyclacel pharmaceuticals dailyCyclacel pharmaceuticalsCyclacel pharmaceuticals incGet free reportPharmaceuticals trading downCyclacel pharmaceuticals daily

Cyclacel Pharmaceuticals, Inc (NASDAQ:CYCC) Short Interest Up 58 0% in April

Cyclacel Pharmaceuticals, Inc (NASDAQ:CYCC) Short Interest Up 58 0% in April
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

News ratings for cyclacel pharmaceuticals dailyCyclacel pharmaceuticals incCyclacel pharmaceuticalsCyclacel pharmaceuticals trading downGet free reportPharmaceuticals trading downCyclacel pharmaceuticals daily

StockNews com Begins Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC)

StockNews.com began coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research report sent to investors on Monday. The brokerage issued a sell rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Trading Down 5.3 % Shares of CYCC opened at $3.19 on Monday. Cyclacel Pharmaceuticals has a 12-month low of $3.07 and […]

Hedge funds weigh in on cyclacel pharmaceuticalsCyclacel pharmaceuticals company profileCyclacel pharmaceuticals trading downCyclacel pharmaceuticals incCyclacel pharmaceuticalsMillennium managementRenaissance technologiesVirtu financialNews ratings for cyclacel pharmaceuticals dailyFree reportPharmaceuticals trading downGet free reportSigma investmentsCyclacel pharmaceuticals dailyNasdaq cyccInitiated coverage

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Receives New Coverage from Analysts at StockNews com

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Receives New Coverage from Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Renaissance technologiesCyclacel pharmaceuticalsVirtu financialInstitutional trading of cyclacel pharmaceuticalsCyclacel pharmaceuticals incCyclacel pharmaceuticals company profileCyclacel pharmaceuticals trading downNews ratings for cyclacel pharmaceuticals dailyMillennium managementFree reportPharmaceuticals trading downGet free reportTwo sigma investmentsCyclacel pharmaceuticals daily

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Earns Sell Rating from Analysts at StockNews com

StockNews.com started coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research report released on Monday. The firm issued a sell rating on the biotechnology company’s stock. Separately, Oppenheimer lowered their target price on shares of Cyclacel Pharmaceuticals from $10.00 to $8.00 and set an outperform rating for the company in a […]

Cyclacel pharmaceuticalsVirtu financialRenaissance technologiesCyclacel pharmaceuticals company profileInstitutional investors weigh in on cyclacel pharmaceuticalsSchonfeld strategic advisorsCyclacel pharmaceuticals incMillennium managementCyclacel pharmaceuticals trading downNews ratings for cyclacel pharmaceuticals dailyFree reportPharmaceuticals trading downStrategic advisorsSigma investmentsCyclacel pharmaceuticals dailyNasdaq cycc